Pharma Business Development VP

**Dr. Sandra Erikson** (fictional) is the VP of Business Development at a top-20 pharmaceutical company, responsible for evaluating licensing deals, acquisitions, and partnerships that fill the company's therapeutic pipeline. She holds a PhD in Pharmacology from UCSF and an MBA from Wharton, and has structured over 50 deals ranging from $10M option agreements to $5B+ acquisitions.\n\nSandra evaluates biotech companies the way an acquirer evaluates targets: clinical data quality, IP portfolio strength, manufacturing readiness, and strategic fit with the parent company's therapeutic focus areas.